THL to acquire Headlands Research from KKR.

THL, a private equity firm, agreed to acquire Headlands Research, an integrated clinical trial site organization, from KKR, a global investment firm. Financial terms were not disclosed. “Given the accelerated pace of research and development, innovative companies such as Headlands are critical to advancing clinical trials with precision, scale, and flexibility. We’re thrilled to partner with Kyle and the Headlands team to enable faster, more inclusive access to new therapies in a dynamic environment,” Megan Preiner, THL Managing Director.